Morgan Stanley Vyant Bio, Inc. Transaction History

Morgan Stanley

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$0.52 - $0.89 $1 - $2	3 Added 0.01%	20,052 $11,000
Q2 2022 Oct 27, 2022	SELL	$0.62 - $1.37 $13 - $30	-22 Reduced 0.11%	20,049 $18,000
Q2 2022 Aug 15, 2022	SELL	$0.62 - $1.37 $13 - $30	-22 Reduced 0.11%	20,049 $18,000
Q1 2022 Oct 27, 2022	BUY	$0.99 - $1.61 $21 - $35	22 Added 0.11%	20,071 $29,000
Q1 2022 May 13, 2022	SELL	$0.99 - $1.61 $17,799 - $28,946	-17,979 Reduced 47.25%	20,071 $29,000
Q3 2021 Nov 15, 2021	BUY	$2.26 - $3.74 $85,992 - $142,307	38,050 New	38,050 $89,000

213K

Ticker VYNT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,343,200
Description
Vyant Bio, Inc., a biotechnology company, discovers drugs for complex neurodevelopmental and neurodegenerative disorders. The company's central nervous system (CNS) drug discovery platform combines human-derived organoid models of brain disease, scaled biology, and machine learning. It focuses on identifying repurposed and novel small molecule c...

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

Stay updated on Morgan Stanley with notifications on news.